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Abstract
We investigated the effects of AMPK on H2O2-induced premature senescence in primary human keratinocytes. Incubation
with 50 mMH 2O2 for 2 h resulted in premature senescence with characteristic increases in senescence-associated ß-
galactosidase (SA-gal) staining 3 days later and no changes in AMPK or p38 MAPK activity. The increase in SA-gal staining
was preceded by increases in both p53 phosphorylation (S15) (1 h) and transactivation (6 h) and the abundance of the
cyclin inhibitor p21
CIP1 (16 h). Incubation with AICAR or resveratrol, both of which activated AMPK, prevented the H2O2-
induced increases in both SA-Gal staining and p21 abundance. In addition, AICAR diminished the increase in p53
transactivation. The decreases in SA-Gal expression induced by resveratrol and AICAR were prevented by the
pharmacological AMPK inhibitor Compound C, expression of a DN-AMPK or AMPK knock-down with shRNA. Likewise,
both knockdown of AMPK and expression of DN-AMPK were sufficient to induce senescence, even in the absence of
exogenous H2O2. As reported by others, we found that AMPK activation by itself increased p53 phosphorylation at S15 in
embryonic fibroblasts (MEF), whereas under the same conditions it decreased p53 phosphorylation in the keratinocytes,
human aortic endothelial cells, and human HT1080 fibrosarcoma cells. In conclusion, the results indicate that H2O2 at low
concentrations causes premature senescence in human keratinocytes by activating p53-p21
CIP1 signaling and that these
effects can be prevented by acute AMPK activation and enhanced by AMPK downregulation. They also suggest that this
action of AMPK may be cell or context-specific.
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Introduction
Ageing is a physiological phenomenon that occurs in all
eukaryocytes. In many tissues, it is associated with an increased
number of senesced cells [1,2]. Although senescent cells undergo
an apparently irreversible growth arrest, they remain metabolically
active and display characteristic changes in cell morphology,
physiology and gene expression and a resistance to apoptosis. In
addition, they produce inflammatory and other factors that can
have adverse effects on adjacent cells that in turn could contribute
to various disorders [1]. Recently it has been reported that
elimination of senescent cells in a mouse with a progeroid
background delays the development of an aging phenotype in
various organs [3]. Thus, cellular senescence could also play a
critical role in aging in vivo.
Replicative senescence, first described in cultured human
fibroblasts 50 years ago [4], is the result of erosion of telomeres
and occurs at every cell division. The definition of senescence has
since been broadened, and it is now accepted that a senescence
phenotype can occur irrespective of telomere status [5]. This so
called ‘‘premature’’ senescence may be caused by oxidative and
other stresses that cause DNA damage, chromatin perturbation
(e.g. by histone acetylation), oncogenes and other factors [1]. It has
also been established that the activation of p53 and p38 MAPK,
and subsequent to this the induction of their cyclin-dependent
kinase (CDK) inhibitors, p21
CIP1 and p16
INK4a, can be key factors
in producing and maintaining growth arrest in these cells [6]. A
defining characteristic of cells with both replicative and premature
senescence is an increase in the staining of senescence-associated
b-galactosidase (SA-Gal) [2].
Skin is the largest organ in the body and its epidermis is self-
renewing and metabolically very active. Epidermis, especially of
skin on the face, is exposed to UV light that leads to oxidative
stress and DNA damage that, in turn, predispose it to various
diseases including cancers, as well as to changes that give it the
characteristic appearance of aging [7]. In keeping with this,
senescent cells, positive for SA-Gal activity, were first described in
vivo in the epidermis of aged humans [2]. Also, exposure of
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5 day period, has been shown to induce premature senescence, as
evidenced by decreased population doublings and increased SA-
Gal positive cells [8]. In the studies described here, we used a
similar model in which keratinocytes were exposed only once to
H2O2 to examine the effects of the fuel sensing and signaling
molecule AMP-activated protein kinase (AMPK) on these events.
AMPK is a heterotrimeric enzyme that consists of a, b and c
subunits [9]. It initially drew attention because of its role in sensing
a cell’s energy state and restoring it to normal values when low.
Thus, increases in the AMP/ATP ratio (low energy state) have
repeatedly been shown to lead to AMPK activation, which in turn
activates various processes that increase ATP generation (e.g. fatty
acid oxidation, mitochondrial function) and decreases others that
consume ATP, but can be downregulated without compromising
the cell (e.g. protein and lipid synthesis, cell growth and
proliferation) [10]. More recent studies suggest that AMPK plays
a much wider role in the regulation of cellular function. In
particular it appears to be a major factor in combating many
stresses. For instance, in human endothelial cells, activation of
AMPK by AICAR (aminoimidazole carboxamide ribonucleotide)
and other agents has been shown to prevent the apoptosis,
mitochondrial dysfunction, insulin resistance, inflammation and
oxidative stress caused by hyperglycemia [11,12,13], the fatty acid
palmitate [14]; and TNFa [14,15]. In addition, in various tissues
AMPK has been shown to affect genes that regulate mitochondrial
function [16]; the expression of anti-oxidant enzymes [17]; the
phosphorylation of transcriptional factors such as p53 and the
FOXOs [18,19]; cellular autophagy [20,21] and polarity [22,23]
and the activity of SIRT1, a histone protein deacetylase that has
been linked to increased longevity [24]. Furthermore AMPK
appears to regulate, at least in part, the therapeutic benefits of
exercise and a variety of pharmacological agents (e.g. metformin,
thiazolidinediones) in experimental animals and where studied in
humans [25,26].
Despite its many actions, the effects of AMPK on cellular
senescence have received relatively little attention. In two widely
quoted studies, this question was examined in cultured fibroblasts.
In one of them, Jones et al [19] found that AICAR treatment or
overexpression of a CA-AMPK in mus musculus embryonic
fibroblasts (MEF) led to p53 phosphorylation on S15 and growth
arrest within hrs and over a longer period of time (days) to
increased SA-Gal staining. They also found that growth arrest and
enhanced SA-Gal activity did not occur in MEFs lacking p53. A
similar effect of prolonged AMPK activation (3–7 days) on
senescence was also reported in human fibroblasts incubated with
pharmacological AMPK activators (AICAR, antimycin A, azide)
by Wang et al [27]. In this study, replicative senescence was
associated with an increase in the AMP/ATP ratio, and increased
p16, as well as activation of AMPK. The phosphorylation of p53
was not studied.
In light of the above findings, we have examined the effects of
AMPK on cellular senescence in keratinocytes. For this purpose,
primary human keratinocytes were incubated with a low dose of
H2O2 that induces a senescent phenotype [8]. We examined the
events associated with the development of senescence in these cells,
and in particular whether AMPK activity is altered and/or its
activation attenuates or accelerates the senescence. In addition, we
compared the effects of AMPK on p53 phosphorylation, a key
event in the development of senescence, under identical conditions
in keratinocytes, MEFs and other cells.
Results
Establishment of conditions for inducing premature
senescence in primary human keratinocytes
Previous reports suggest that keratinocytes may undergo
apoptosis or premature senescence depending on the dose of
H2O2 to which they are exposed [8,28]. Thus, we initially
examined the effects of different doses of H2O2 on cell viability.
The alamar blue assay was used to measure viability 16 hours after
a 2 hr exposure to H2O2 at the indicated concentrations (see
Materials and Methods). As shown in Figure 1a, increasing the
concentration of hydrogen peroxide progressively decreased cell
viability, and after exposure to 250 mM for 2 hrs virtually no
viable cells were observed at 16 h. Next we assessed whether
exposure to lower doses of hydrogen peroxide induces premature
senescence as previously reported [8] and if so, at what time post
exposure. H2O2 at a dose of 50 or 100 mM was added to the
culture medium for 2 h at day 3 post seeding and the cells were
refed standard growth medium and cultured up to 8 days. By 3–4
days post H2O2 exposure, the keratinocytes treated with these
concentrations of H2O2 were viable, variable in size and less
densely populated than control cells. In addition, strong positive
staining for SA-Gal was seen in some, but, not all cells (Fig. 1b),
with the percentage of SA-Gal positive cells increased by 3.5 fold
(p,0.01) (Fig. 1c). These experiments were repeated several times
with keratinocytes from different individuals and passaged up to 4
times with similar results. As shown in Fig. 1d, incubation with
50 mMH 2O2 for 2 hrs did not increase SA-Gal staining after 16 or
40 hrs, but did so at 64 hrs. Likewise, we obtained identical
findings when H2O2 was added twice, once at 3 days post seeding
for 2 hours and again once at 5 days post-seeding for 2 hours, in
keeping with the findings of Bernard et al. [8]. Since a single
exposure of H2O2 was sufficient to cause senescence 64 hrs post
exposure, we used this model in subsequent studies.
Assessment of the expression of AMPK upstream
regulators and downstream targets when hydrogen
peroxide induces senescence
Primary keratinocytes possess a functional AMPK cascade that
is upregulated by AICAR, rosiglitazone and increases in cell
density [29]. In the present study, we found that primary human
keratinocytes express both the alpha 1 and 2 isoforms of AMPK,
with alpha1 the dominant isoform (see below), as well as the two
major AMPK kinases, CaMKK and LKB1-STRAD-MO25
(Fig. 2a). The results also revealed that LKB1 and SIRT1, which
can be an upstream regulator of LKB1 ([30] and see below), are
predominantly localized in the nucleus (Fig. 2b).
Sixty-four hrs after a single 2 hour treatment with 50 mM
hydrogen peroxide, i.e., when the senescence phenotype was
observed, the expression of AMPK alpha 2, CaMKK2, Strad
alpha and beta and SIRT1 were all markedly decreased (Fig. 1a).
AMPK alpha 1 and LKB1 were moderately decreased and
CaMKK1 and MO25 unchanged. Thus, overall the AMPK
signaling system was down-regulated in senesced cells. In keeping
with this conclusion, the protein expression of various AMPK
targets, including both ACC (acetyl-CoA carboxylase) and FAS
(fatty acid synthase), which AMPK transcriptionally downregu-
lates, was increased and that of the house-keeping gene GAPDH
was unchanged (Fig. 2a). Immunocytochemistry revealed a loss of
nuclear LKB1 and AMPK; however, SIRT1 staining was not
noticeably altered (Fig. 2c).
AMPK and Senescence
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negative (DN)-AMPK causes a senescent-like phenotype
We next attempted to evaluate the effects of AMPK down-
regulation on primary human keratinocytes in the absence of
H2O2. As observed with many other primary cells, the
keratinocytes were not easily transfected by traditional lipid-based
agents. Thus, we chose to use recombinant viruses. In preliminary
experiments, three different recombinant virus systems were
evaluated; adenovirus [31], adeno-associated virus (AAV type 2),
and lentivirus. Viruses expressing GFP proteins were tested to
assess the feasibility of using each of them. We found that human
keratinocytes can be infected with all three. Infection of GFP
expressing adenovirus and AAV had no effect on cell growth or
morphology or SA-Gal staining compared to non-infected cells
and GFP expression was evident for at least 1 week (Fig. 3 and Fig.
S1).
Based on these results, we evaluated the effects of infection with
recombinant adenovirus expressing myc-tagged dominant nega-
tive (DN) alpha1-AMPK. Such keratinocytes were easily detected
by immunocytochemical staining of their cytosol with myc-
antibody (Fig. 3). SA-Gal staining was still visible, although its
intensity was diminished because of repeated washing during
immunostaining. Almost all DN-AMPK positive cells were SA-Gal
positive and larger in size, suggesting that endogenous AMPK
activity regulates senescence in the keratinocyte. Similar findings,
obtained when keratinocytes were infected with a lentivirus
expressing shRNA targeting AMPKa1, will be presented later in
conjunction with studies with AMPK activators.
Activation of AMPK by AICAR or resveratrol prevents
hydrogen-peroxide induced senescence
We next assessed the effect of AMPK activation on hydrogen
peroxide induced premature senescence. AICAR, a widely used
AMPK activator, and resveratrol, a putative direct activator of
both AMPK and SIRT1 [32] were used. AICAR activates AMPK
when it is converted in cells to ZMP (5-aminoimidazole-4-
carboxamide-1-b-D-ribofuranosyl-5-monophosphate), an AMP
analog, and resveratrol is thought to do so both by activating
SIRT1, which deacetylates LKB1, leading to its activation and
then to that of AMPK [30] and by a direct action on mitochondria
that leads to a charge in cellular energy state. As shown in (Fig. 4a),
both AICAR and resveratrol activated AMPK in 2 hours or less.
We added AICAR 1 hour before hydrogen peroxide treatment
and, as in other studies, replaced the basic medium with growth
Figure 1. Effects of H2O2 on cell viability and senescence. a. Cell viability was assessed by alamar blue fluorescence (Ex 530, Em. 590 nm) 16 hr
after the addition of H2O2 at the indicated concentrations (n=6, ** p,0.01). Incubation with H2O2 at concentrations between 50–250 mM
progressively decreased cell viability. b. SA-galactosidase (SA-Gal) activity. Cells were incubated in media containing the indicated concentration of
H2O2 for 2 hr. They were then incubated in the same medium without H2O2 for 3–4 days, after which they were stained for SA-Gal. H2O2 increased
the number of positive cells. c. Percentage of positive cells was increased approximately 3-fold by prior incubation with 50 or 100 mMH 2O2. In excess
of 300 cells were counted for each condition. (n=3–6, ** p,0.01) d. Time course of appearance of SA-galactosidase positive cells after treatment
with 50 mMH 2O2.
doi:10.1371/journal.pone.0035092.g001
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after 64 hr, prior incubation with 50 mMH 2O2 caused a 4-fold
increase in the percentage of SA-Gal positive cells (2.560.26%
(control) vs 9.661.2%, n=6, p,0.001), and AICAR totally
prevented this (2.260.4%). Cell viability assessed with alamar blue
was slightly decreased in cells treated with 50 mM hydrogen
peroxide (p,0.05, n=3) and this too was prevented by AICAR
(Fig. 4c). In a separate experiment, we tested whether prevention
of AMPK activation by infection with a dominant negative (DN)-
AMPK, 2 days prior to the experiment, affected AICAR’s ability
to prevent senescence. As shown in Fig. 4d, it totally eliminated
AICAR’s ability to do so, further indicating that its protective
action was AMPK mediated.
To evaluate further the effects of AMPK on premature
senescence we performed AMPK knock-down experiments using
short interference (si) or short hairpin (sh) RNA. Transfection of
commercially prepared siRNA resulted in unsatisfactory decreases
in both AMPK alpha 1 and 2 (not shown), likely due to difficulty in
its transfection in primary keratinocytes. Thus, we made lentivirus
vectors expressing shRNA to either alpha1 or alpha2. Among 3
vectors created (2 for alpha1 and 1 for alpha2), we found one
which targeted alpha1 that suppressed AMPK alpha1 by more
than 95% and total AMPK by 80–90% (Fig. 5a.) 48 hrs after
transduction. Subsequently, we infected keratinocytes with lenti-
viruses expressing shRNA targeting a non-human sequence
(shControl) or AMPK alpha1 (shAMPKa1) 48 hours before
applying H2O2. As shown in Fig. 5 bc, knock-down of AMPK
by itself resulted in a two-fold increase in SA-Gal positive cells and
it eliminated the effects of AICAR completely.
The effects of resveratrol, added 30 min prior to H2O2, were
studied in the presence and absence of the AMPK inhibitor
Compound C [33](Fig. 6a). As shown in the western blot,
Compound C completely eliminated the increase in phospho
T172-AMPK caused by resveratrol (Fig. 6b) as well as its ability to
prevent H2O2 induced cellular senescence (Fig. 6c). Thus,
Figure 2. Effects of H2O2 on the expression of AMPK and some of its upstream regulators and down-stream targets. a. Western blot
analysis. Cells were grown on a 6 well plate. In three wells they were treated with 50 mMH 2O2 for 2 hrs, 5 days after seeding to produce senescence.
Sixty four hours after exposure to H2O2, the treated and control cells were harvested for SDS-PAGE and western blotting. After adjusting for
differences in protein concentration, lysates from 3 wells in the same treatment group were combined to minimize variation and proteins were
separated on 4–12% gradient gels and then transferred to a PDVF membrane. In keratinocytes treated with H2O2, the expression of AMPK alpha 2,
CaMKK2, Strad alpha and beta and SIRT1 were all diminished. Modest decreases in AMPK alpha 1, and LKB1 expression were also observed, whereas
CaMKK1 and MO25 were not affected. Thus the AMPK system was down-regulated in senesced cells. In agreement with this conclusion, both ACC
and FAS expression were increased. Results are representative of 3 measurements. b, c. Immunocytochemical analysis of AMPK, LKB1 and
SIRT in control (b) and H2O2 treated cells at 64 hr (c). Control cells and cells treated with 50 mM hydrogen peroxide were incubated as
described in 2a. At sixty four hours, they were fixed with 2% paraformaldehyde and incubated with the indicated primary antibodies and detected
with the UltraTech HRP kit and NovaRed. Figures in (c) were selected to show enlarged-senescent cells and control cells. AMPK staining was observed
in the nucleus as well as the cytosol, suggesting the presence of both its alpha 1 (cytosol) and alpha2 (cytosol and nucleus) isoforms. Both LKB1 and
SIRT1 were predominantly stained in the nucleus. (scale bar=50 mm). Following H2O2 treatment the nuclear localization of AMPK and LKB1, but not
SIRT1, was lost in senesced cells (c). The photomicrographs in (c) were selected to show enlarged senescent cells and are not representative of the
population as a whole, as thet are in Figures 1,3 (scale bar=100 mm). Results are representative of 3 experiments.
doi:10.1371/journal.pone.0035092.g002
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crucial for its ability to inhibit H2O2 induced senescence.
P53, but not p38MAPK or AMPK, is activated by low
doses of hydrogen peroxide
We examined the effects of H2O2 at various concentrations on
the phosphorylation and/or abundance of AMPK, p53, p21 and
LKB1 in primary keratinocytes. When studied 1 hr after the
addition of 50 or 100 mMH 2O2, AMPK activity, assessed both by
the phosphorylation of its alpha subunit at T172 (Fig. 7a) and of its
substrate ACC (acetyl-CoA carboxylase, Fig. 7b), was not
substantially altered, nor was the phosphorylation of the AMPK
kinase LKB1 at S431. In contrast, the phosphorylation of all of
these molecules was increased after incubation with 250 mMH 2O2
(Fig. 7c).
In contrast to the lack of change in AMPK, ACC and LKB1,
p53 abundance at 1 h was increased by 50% at 50 and 100 mM
H2O2, but was decreased at 250 mM (Fig. 7d). Also p53
phosphorylation at S15, an index of its activation, was dramat-
ically increased by 50 and 100 mMH 2O2 and to a lesser extent by
250 mMH 2O2 (Fig. 7e). No detectable p38MAPK phosphoryla-
tion was observed at 50 and 100 mMH 2O2, even after 24 hrs (not
shown); but, such phosphorylation was strongly increased at
250 mMH 2O2 (Fig. 7f). Finally, incubation with a low dose of
H2O2 (50 mM) increased the abundance of p21
CIP1, but not p16 at
16 h (Fig. 7g). Taken together, these findings indicate that low-
doses of H2O2 activate p53, but not AMPK or p38MAPK. They
also suggest that the senescence induced by low dose hydrogen
peroxide is caused by activation of the p53-p21
CIP1, but not the
p38MAPK-p16
INK4a cascade.
H2O2-induced increase in p21
CIP1 requires p53 and is up-
regulated by AMPK knock-down
Since p21
CIPI is a well-known target of p53, induction of p21
CIPI
by H2O2 is likely the result of p53 activation. In keeping with this
conclusion, when p53 was knocked-down by infecting keratino-
Figure 3. Adenovirus mediated gene transfer and the effects of dominant negative (DN) AMPK expression on SA-Gal staining and
morphology. Cells were infected with recombinant adenovirus expressing myc-tagged DN-AMPK 4 days after seeding. Immunohistochemical
staining with myc-antibody was performed following SA-Gal staining. Infected cells were easily detected by cytosolic staining with myc-antibody. SA-
Gal staining was diminished by repeated washing during immuno-staining but was still detectable. Almost all infected cells were enlarged and
stained positively for SA-Gal.
doi:10.1371/journal.pone.0035092.g003
Figure 4. Effects of AMPK activation by AICAR (1 mM) on H2O2 induced SA-galactosidase expression. a. AICAR increased Thr172
phosphorylation of AMPK in 2 h and resveratrol in 30 min–2 hrs. (n=3, * p,0.05, ** p,0.01) b. Effects of AICAR on SA-Gal activity. Cells were treated
with 1 mM AICAR 2 hrs prior to exposure to 50 mMH 2O2. SA-Gal activity was assessed 64 hrs later. c. Cells were treated as in b., except that after
16 hrs cell viability was assessed after incubation with alamar blue for 1 hr (n=3–6, ** p,0.01). d. Effect of dominant negative (DN)-AMPK adenovirus
infection on the suppression of H2O2 induced SA-galactosidase expression by AICAR. DN-AMPK expressing adenovirus was added to the cells 24 hrs
before the experiment. (n=3, ** p,0.01 vs control).
doi:10.1371/journal.pone.0035092.g004
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increase in p53 protein caused by H2O2 was prevented and the
induction of p21
CIP1 was completely inhibited (Fig. 8a), We also
examined effects of AMPK knock-down on p53 and p21
CIPI.
Consistent with the results shown in fig. 5, AMPK knock-down
strongly induced p21
CIPI with a modest increase in p53 (Fig. 8b).
Inhibition of p21
CIP1 expression by AMPK is associated
with decreased p53 transactivation
The increase in the abundance and nuclear localization of the
p21
CIPI preceded the increase in SA-Gal in keratinocytes
incubated with 50 mMH 2O2 (16 h vs 40–64 h). The data in
Figure 5. Effects of AMPK knock-down with shAMPKa1 on SA-galactosidase expression. a. Lentivirus vectors expressing shRNA targeting
human AMPK alpha subunit were created. One of them knocked-down the AMPK alpha1 subunit more than 95%, 48 hours after infection, without
affecting alpha2 expression. Total AMPK alpha was suppressed more than 80%. b, c. Keratinocytes grown in 12 well plates were infected with
lentivirus expressing control (non-targeting) shRNA (shControl) or AMPK alpha1 (shAMPKa1) 48 hours prior to incubating for 2 hours with
H2O261 mM AICAR SA-Gal activity was assessed 64 hours later. In fection of the cells with shAMPKa1 both significantly increased basal SA-Gal
(*, p,0.05 vs shControl+0m MH 2O2, n=4) and eliminated the preventive effects of AICAR ({,p ,0.05 vs shAMPKa1+0m MH 2O2, n=4).
doi:10.1371/journal.pone.0035092.g005
Figure 6. Effects of resveratrol and the AMPK inhibitor Compound C on H2O2 induced SA-galactosidase expression. a. Basic
experimental design. b. AMPK activation by resveratrol and its inhibition by Compound C. c. Inhibition of H2O2 induced senescence by resveratrol
and its prevention by Compound C. SA-Gal staining was performed 64 hrs after the cessation of H2O2 treatment (n=3, ** p,0.01 vs control).
doi:10.1371/journal.pone.0035092.g006
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reservatrol (30 mm) totally prevents this increase in nuclear
p21
CIPI. To evaluate whether this effect of AICAR was mediated
by p53 we determined p53 phosphorylation at 1 hr and its
abundance at 1 hr and 16 hr post H2O2 treatment. In addition, its
p53 transactivation (assessed by the fire-fly luciferase reporter gene
assay) was determined 6 hr after the addition of hydrogen
peroxide. As shown in Fig. 8e, f, at 1 h AICAR did not diminish
the increase in p53 phosphorylation (S15) and it modestly
enhanced the increase in p53 abundance caused by H2O2.1 6h
post- H2O2, p53 abundance was neither increased compared to a
control group (no H2O2) nor was it altered by AICAR (Fig. 8g).
Finally, p53 transactivation was increased 16 h after H2O2
treatment and preincubation with AICAR totally prevented this
(Fig. 8h). Thus, it appears that AMPK could act initially by
inhibiting p53 transactivation and subsequent to this p21
CIP1
induction when it prevents the premature senescence caused by
low doses of H2O2.
Activation of AMPK by AICAR does not induce
phosphorylation of p53 in keratinocytes
As noted in the Introduction, in cultured embryonic fibroblasts
(MEF), activation of AMPK by 1 mM AICAR increases p53
phosphorylation at S15 and accelerates senescence [19]. Since we
found here that AMPK activation diminishes H2O2-induced
senescence in keratinocytes, we examined the effects of incubation
with AICAR on p53 phosphorylation (S15 for human S18 for
MEF) in the two cell types. As shown in Fig. 9A, we did not
observe an increase in p53 phosphorylation in keratinocytes after a
2-hour incubation with 1 mM AICAR (Fig. 9a), despite robust
AMPK activation as evidenced by specific increases in AMPK and
ACC phosphorylation. Consistent with Fig. 7a, 50 mMH 2O2
markedly increased p53 phosphorylation at S15 (Fig. 9a), although
it did not activate AMPK (pAMPK). Next, we examined the
effects of 16 hours of continuous incubation with 1 mM AICAR,
which has been reported to increase p53 phosphorylation in
embryonic fibroblasts (MEF) [19]. As shown in Fig. 9b, AICAR
increased the phosphorylation of the AMPK substrate ACC in
both cells, but it increased p53 phosphorylation at S15 only in the
MEF (3-fold, p,0.01, n=3). In keratinocytes, both the abundance
(p53/GAPDH) and phosphorylation (p-p53/p53 ratio) of p53
were decreased by 35% (p,0.01, n=3). We next investigated this
phenomenon in various cell types. As summarized in Fig. 9c,
AICAR caused robust increases in p53 phosphorylation (3–4 fold,
p,0.01, n=3 each) in two fibroblast cultures (MEF1 and MEF2),
but in other cell types including keratinocytes, human fibrosarco-
ma cells (HT1080) and adult human aortic endothelial cells
Figure 7. AMPK, LKB1, p53, p21, and p16 protein expression after H2O2 exposure for 1 and 16 hr. Keratinocytes were treated with the
indicated concentration of H2O2 and harvested after 1 hr (a–f) or16 hr (g.) for western blotting (a,b). AMPK activity, assessed by its phosphorylation
at Thr172 and that of its substrate ACC Ser79, was increased only at the high (250 mM) concentration of H2O2(c). Phosphorylation of LKB1 (Ser431), an
upstream kinase of AMPK, was slightly decreased by 50 mMH 2O2 and increased by 250 mMH 2O2 (d, e). p53 expression and phosphorylation were
increased by 50 and 100 mMH 2O2 and were variably affected by 250 mMH 2O2 (f). Activation (phosphorylation) of p38-MAPK was only observed with
250 mMH 2O2. g. Incubation with H2O2 (50 mM) for 16 h induced the cyclin-dependent kinase inhibitor, p21
CIP1 but not p16
INK. (n=3–6, * p,0.05,
** p,0.01).
doi:10.1371/journal.pone.0035092.g007
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30–35% (p,0.01, n=3 each). Such diverse results were observed
despite similar (3–5 fold) increases in ACC phosphorylation in all
of the cell types tested. Collectively, these findings strongly suggest
that although p53 can be a substrate of AMPK, the effects of
AMPK activation on p53 phosphorylation at S15 are cell-type
dependent.
Discussion
We show here that H2O2-induced premature senescence in
primary human keratinocytes can be prevented by AMPK
activation. Thus, we found that: (1) a low dose of H2O2 (50 mM)
activated p53 and secondarily p21
C1P1 in these cells and
subsequently increased SA-Ga1 activity. (2) AMPK activity was
not affected by H2O2 at this low dose, but its prior activation by
AICAR or resveratrol prevented these H2O2-induced changes and
(3) AMPK activation appeared to exert these effects, at least in
part, by inhibiting p53 transactivation. In addition to these novel
actions of AMPK, (4) we demonstrated that AMPK-induced p53
phosphorylation is a cell-type dependent phenomenon.
p53 acting on p21
CIP1 has been implicated in the pathogenesis
of cellular senescence in response to DNA damage, telomere
erosion, chromatin perturbation when histone deacetylase activity
is diminished, and other stresses [1]. Senescence can also be
Figure 8. Effects of p53 or AMPK knock-down and AMPK activation on p21 and p53 expression. a. Effects of p53-knockown on p53
and p21
CIP1expressions. Cells grown on 6 well plates were infected with lentiviral vector, expressing short-hairpin (sh) RNA targeting non-human
sequence (Control) or p53, at 30% confluence. Forty-eight hours later, cells were treated with 50 mMH 2O2 for 2 hr, and harvested after 1 hr (for p53
expression) or 16 hours (p21
CIP1 expression). The knock-down of p53 completely blocked H2O2 induced upregulation of p53 and subsequent in
p21
CIP1. Experiments were performed in duplicate and representative blots are shown. b. Effects of AMPK knock-down on p53 and p21
CIP1
expression. AMPK knock-down effects were assessed as in the preceding experiment. Cells were harvested at 16 hr after H2O2 treatment. AMPK
knock-down increased both p53 and p21
CIP1 expression and H2O2 increased p21
CIP1 further. Experiments were performed in duplicate and a
representative blots is shown. The result is consistent with the increased SA-Gal expression casued by AMPK knock-down as shown in fig. 5. c, d.
Effects of AICAR and resveratrol on H2O2 induced p21
CIP1 expression. (c.) Cells grown on 6 well plates were treated with 50 mMH 2O2 for
2 hr with/without 30 min pretreatment with 50 mM resveratrol or 1 mM AICAR. After sixteen hours of incubation, in standard growth medium, the
cells were fixed with 2% paraformaldehyde and immunostained for p21
CIP1.H 2O2 significantly increased positive staining in the nucleus (non-specific
staining can be seen in cytosol), and this was largely prevented by AICAR and resveratrol. Scale bar=50 mm. (d.) Quantitation of 150–200 cells from
(a) revealed that approximately 50% of cells treated with hydrogen peroxide exhibited predominantly nuclear staining of p21
CIP1 and that AICAR and
resveratrol completely prevented this from occurring. (n=3, ** p,0.01). e–f. Effects of AICAR on H2O2-induced p53 expression and
phosphorylation. (e.) p53 phosphorylation was increased by H2O2 exposure and this was not affected by AICAR (n=3, ** p,0.01 vs 6). (f.) Cells
were incubated with 1 mM AICAR for 1 hr prior to addition of 50 mM H2O2 and then harvested 1 hr later. p53 protein abundance was increased by
H2O2 and AICAR had an additive effect on this. e. Increases in p53 abundance in H2O2 only and H2O2+AICAR groups observed at 1 hr were not
observed at 16 hr. g. p53 reporter gene assay. The cells were infected with a p53-luciferase reporter adenovirus. Twenty-four hours later, one
group was pre-treated for 1 hr with 1 mM AICAR then given 50 mH2O2. Six hours later the cells were harvested and luciferase activity assessed.
Luciferase activity, which reflects p53 transactivation, was significantly increased by H2O2 and was suppressed by 1 mM AICAR. (n=4, p,0.05 for
both).
doi:10.1371/journal.pone.0035092.g008
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INK induction through p38 MAPK activation, but
our data showed this cascade does not appear to play a significant
role in the pathogenesis of H2O2-induced senescence in keratino-
cytes when stimulated with H2O2. Our observations are in line
with a recent report that demonstrated whole-body elimination of
p16
INK activated cells has no effect on skin aging in the mouse in
vivo, whereas it significantly improves the phenotype of many
other organs [3]. In the present study, we found that activation of
AMPK by both AICAR and resveratrol failed to diminish the
increase in p53 phosphorylation when it prevented the increase in
SA-Gal expression caused by low dose H2O2. Instead, it decreased
p53 transactivation (6 hr) and totally prevented the increase in
p21
C1P1. As will be discussed later, this is in contrast to the findings
of others in different cell types. Mechanistically, our data suggest
that AMPK acutely regulates p53’s ability to transactivate its
target genes in keratinocytes. How it does so remains to be
Figure 9. Effects of 1 and 16 hr of AICAR incubation on p53 phosphorylation in keratinocytes, MEFs and other cells. a. Primary
keratinocytes were incubated with 1 mM AICAR or 50 mMH 2O2 (positive control) for 1 hr. As compared to H2O2 treatment, incubating the cells with
1 mM AICAR did not increase p53 phosphorylation despite a robust increase in pAMPK and pACC. b. Primary keratinocytes and embryonic fibroblasts
(MEF), were incubated with 1 mM AICAR for 16 hrs to examine its effects on p53 abundance and phosphorylation at S15. AICAR increased AMPK
activity, as evidenced by a 3–5 fold increase in the pACC/ACC ratio in both cells. In contrast, p53-phosphorylation was increased in MEF but was
decreased in keratinocytes. c. Fold changes in pACC/ACC and p-p53/p53 in human keratinocytes, MEFs, HT1080 human fibrosarcoma cells and adult
human aortic endothelial cells (HAEC). Cells were incubated with AICAR for 16 h as in b. Control cells (fold change 1) were incubated with standard
medium without additions.
doi:10.1371/journal.pone.0035092.g009
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by it, modifies p53 so that it does not bind to its cis-regulatory
elements, such as those found on the p21 promoter (i.e. inhibition
of DNA binding). Alternatively, AMPK could phosphorylate and
inhibit another molecule that p53 binds to or recruits to promoters
and that this prevents p53-mediated transactivation. The latter
could include other transcription factors, such as the FOXOs
[18,34] or perhaps members of the RNA Pol II complex required
for transcription.
Another possible mechanism of AMPK regulation of senescence
could be through oxidative stress. Oxidative damage has been
implicated as a major inducer of senescence [1,35], an observation
supported by this study. AMPK activation in turn has been
demonstrated to upregulate anti-oxidant mechanisms that dimin-
ish H2O2 (e.g. an increase in catalase [8,17]), and conversely,
repression of AMPK has the opposite effect. Thus we have shown
that inhibition or knock-down of AMPK increases oxidative stress
in 3T3L1 adipocytes, especially when lipolysis is concurrently
stimulated ([36] and unpublished data) and a similar increase in
oxidative stress has been observed in endothelial cells in which
AMPK is downregulated [13]. Therefore, the increased number of
SA-Ga1 positive cells observed after infection with DN-AMPK
and AMPK knock-down in the present study could have been due
to oxidative stress and conversely, the prevention of senescence by
AMPK activation to its anti-oxidant action.
NF-kB activation also has been shown to cause premature
senescence in primary keratinocytes [8]. According to Acosta [37]
and Kuilman [38] and their coworkers, in oncogene-induced
senescence inflammatory processes in which NF-kB and C/EBPb
are affected, contribute to the activation of p53 and induction of
p21
CIP1 by enhancing the expression of chemokines and receptors.
This is noteworthy, since AMPK has been linked to suppression of
NF-kB signaling. For instance, we have reported that suppression
of AMPK by DN-AMPK intensifies the increase in NF-kB
signaling induced by TNF-alpha and the fatty acid palmitate in
cultured endothelial cells, whereas activation of AMPK inhibits
the ability of both molecules to induce NF-kB activation [14].
The results reported here were obtained in primary human
keratinocytes in early passage and may not apply to other cells.
Thus, several reports have appeared in which AMPK activation
was shown to increase rather than decrease cellular senescence. In
one of them, Wang et al [27], using human fibroblasts as a
replicative senescence model, found that incubation with various
AMPK activators, including AICAR for 3–7 days triggered
senescence characteristics, such as the acquisition of SA-Gal
activity and increased p16
INK4a expression, whereas infection with
a DN-AMPK decreased SA-Gal activity. In subsequent papers,
the authors attributed these events to phosphorylation of importin
a by AMPK [39]. They did not evaluate p53 status, thus it is
difficult to relate their findings to those of the present study. On
the other hand, their data do raise the possibility that AMPK’s role
may differ in cells (situations) in which senescence is p16
INK4a-
mediated. In another study, Jones et al [19] found that persistent
activation of AMPK (days) leads to p53 dependent cellular
senescence in MEFs. When examined here, we confirmed this
finding (Fig. 9) in two groups of cultured MEFs treated with
AICAR. On the other hand, other low passage human primary
cells (keratinocytes, HAEC and skin fibrocytes [data not shown])
and NT1080 human fibrosarcoma cells failed to show increases in
p53 abundance and phosphorylation when treated with AICAR.
Parenthetically, activation of p53 phosphorylation by AMPK has
been reported in rat aortic vascular smooth muscle cells, in which
it also mediated senescence [40] and in a human hepatocellular
carcinoma cell line [41]. Thus, it appears highly likely that the
effects of AMPK activation on p53 phosphorylation and
senescence are cell- and possibly context-specific.
This dual role of AMPK on senescence that varies with cell type
may also apply to some of its other activities. Thus, activation of
AMPK has been shown both to inhibit apoptosis in vascular cells
incubated with high concentrations of glucose [12,42] and the
fatty-acid palmitate [14] whereas it caused apoptosis in cancer cells
treated with such agents as vincristine and doxorubicin [43,44].
The reasons for these opposite effects of AMPK on apoptosis as
well as senescence in different cells remain to be determined.
On the assumption that brief periods of AMPK activation can
protect cultured keratinocytes from becoming senescent, a logical
question is what is the physiological relevance of this finding. As
reviewed elsewhere [1], cellular senescence has become a center of
attention in great measure because of its potential links to cancer
and aging. With respect to cancer, oncogene-induced senescence
has been viewed as a means by which the organism inhibits
neoplastic growth and it could be particularly beneficial in young
people [1]. As already mentioned, epidermal (keratinocyte)
senescence has been noted to increase with age in humans [2].
If so, it would hypothetically protect them against ‘‘cancerous’’
changes and the prevention of senescence by AMPK activators
might not be desirable. On the other hand, it has become
increasingly clear that senescent cells secrete proteins such as
inflammatory cytokines and growth factors that could have
tumorogenic and other adverse effects on adjacent cells
[1,37,38]. If so, the prevention of cellular senescence in skin,
blood vessels, pancreatic b-cells and other sites might have
important benefits [45,46]. In skin, the application of topical
preparations could have the added potential benefit of not
activating AMPK systemically.
In summary, the results demonstrate that premature senescence,
induced by low dose hydrogen peroxide in primary human
keratinocytes, is closely linked to the activation of p53 and
secondarily an increase in nuclear p21
C1P1. They also suggest that
these abnormalities can be prevented by AMPK activators. The
physiological relevance of these findings, and their applicability to
other cell types, remains to be determined.
Materials and Methods
Cell culture
Primary keratinocytes were freshly isolated from infant foreskin
and passage 2–4 cells that had not reached terminal differentiation
were used, as reported previously [47]. No consent form was
needed since keratinocytes were grown from human foreskin tissue
that had been discarded at the time of circumcision. Subjects were
not identified. The protocol was approved by the institutional
review board of Boston University Medical Center. The cells were
isolated, selected and cultured in growth media containing serum
free MCDB-153 medium (Sigma, St. Louis, MO) supplemented
with amino-acids (50 mg/L of L-histidine, 99 mg/L of L-
isoleucine, 14 mg/L of L-methionine, 15 mg/L of L-phenylala-
nine, 10 mg/L of L-tryptophan, and 14 mg/L of L-tyrosine), and
growth factors (1 ml/L bovine pituitary extract, 12.5 mg/L EGF,
2.5 mg/L insulin, and 25 mg/L PGE1). The medium was changed
every other day. On the day of the experiment, the culture media
was changed to basal medium (no growth factors) for 5–6 hrs.
Non-transgenic control embryonic fibroblasts from mus mus-
culus were gifts from Dr. Leonard Guarente at MIT and Dr.
David Sinclair at Harvard. They were obtained in separate
projects, and cultured in DMEM containing 10% FBS. Human
aortic endothelial cells and dermal fibrocytes were purchased from
AMPK and Senescence
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ATCC. All cells were cultured in recommended media.
Hydrogen peroxide treatment, assessment of cell viability
and SA-Gal staining
Cells in basal medium were treated with the indicated
concentration of hydrogen peroxide for 2 hrs. After this, they
were incubated in fresh growth medium without H2O2 for the
remainder of the study. The precise concentration of hydrogen
peroxide in the 30% stock solution (Sigma, St. Louis) was
determined spectrophotometrically by measuring its absorbance
and extinction coefficient at 220 nm. Cell viability was assessed by
incubating the cells at the end of the incubation in a medium
containing alamar-Blue (resazurin) dye (Sigma, St. Louis, MO) for
30 min–2 hr and measuring fluorescence at Ex 530 or 560 and
Em 590 [48]. The alamar blue method has recently replaced the
traditional MTT assay, because of its greater sensitivity and ease of
use. SA-Gal staining was done after paraformaldehyde fixation
with X-Gal at pH 6 [2]. A total of 300–400 cells in 3–4 wells were
evaluated to assess the percentage of SA-Gal positive cells.
AICAR and resveratrol treatment
AICAR was purchased from Sigma (St. Louis, MO) and a
100 mM solution was freshly prepared in PBS. Resveratrol,
obtained from BioMol (Plymouth Meeting, PA), was dissolved in
DMSO and stored at a concentration of 100 mM. Indicated
concentrations of AICAR or resveratrol were added prior to
hydrogen peroxide as described in the text. Two hours after the
addition of hydrogen peroxide, the basal culture medium was
replaced with fresh growth medium.
Recombinant adenoviruses and lentivirus
Recombinant adenovirus expressing DN-AMPK was prepared
as described previously [14]. Adenovirus with p53 consensus
binding sites and a luciferase reporter downstream was created
from Pathfinder vector (Clontech). Approximately 20 MOI of the
viruses were used to infect one well of cells grown in a 6-well plate.
Luciferase activity was assessed as described previously [14]. The
recombinant lentivirus plasmid expressing shRNA targeting
AMPKa1 (TGAATTAAATCCACAGAAA) and p53
(ACATTCTCCACTTCTTGT) were created as described before
[30]. Lentiviruses were packaged in 293T cells and purified using a
kit (lentivirus production kit, ATCGbio.com, Vancouver, Cana-
da). Approximately 20 MOI of the viruses with 8 mg/ml polybrene
were used to infect one well of cells grown in a 12-well plate.
Western blotting
Cells were harvested with lysis buffer and subjected to SDS-
PAGE and western blotting as described previously [30]. The
following primary antibodies were used: pS79 and total Acetyl-
CoA carboxylase, pT172 AMPK and AMPK, pS431 LKB1,
p38MAPK and p21
CIP (Cell Signaling Technologies). LKB1 and
p16
INKantibody was obtained from Santa Cruz Biotechnology.
Statistics
Statistical analysis was performed by one way ANOVA and a
post-hoc Dunnet test using GraphPad Prism (GraphPad Software,
La Jolla, CA). P less than 0.05 was used as an indicator of statistical
significance.
Supporting Information
Figure S1 Keratniocytes were infected with an adenoviral vector
expressing GFP at 40–50% confluency. No morphological changes
were observed as a result.
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